R. Wiest

FxR-modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis

This study shows that FXR agonists reduce bacterial translocation in cirrhosis by stabilizing the gut-vascular barrier and mucus layer.

A multi-scale sub-voxel perfusion model to estimate diffusive capillary wall conductivity in multiple sclerosis lesions from perfusion MRI data